Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071,... BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.721 | -49.3835616438 | 1.46 | 1.49 | 0.6922 | 723257 | 1.26214796 | CS |
| 4 | -0.661 | -47.2142857143 | 1.4 | 1.9 | 0.6922 | 662932 | 1.49555756 | CS |
| 12 | -0.901 | -54.9390243902 | 1.64 | 2.525 | 0.6922 | 1272569 | 1.88059977 | CS |
| 26 | -0.811 | -52.3225806452 | 1.55 | 2.525 | 0.6922 | 1024361 | 1.79890892 | CS |
| 52 | -1.361 | -64.8095238095 | 2.1 | 4.02 | 0.6922 | 816481 | 2.09107278 | CS |
| 156 | -19.616 | -96.3694423974 | 20.355 | 21.68 | 0.6922 | 680534 | 4.06843216 | CS |
| 260 | -29.811 | -97.58101473 | 30.55 | 76.63 | 0.6922 | 569741 | 8.07654417 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
